Is SeaStar Medical Holding Corp (ICU) Halal?

NASDAQ Healthcare United States $10M
✗ NOT HALAL
Confidence: 90/100
SeaStar Medical Holding Corp (ICU) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 74.81% exceeds the 5% threshold allowed under AAOIFI. SeaStar Medical Holding Corp operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 6.0%
/ 30%
19.0%
/ 30%
1.2%
/ 30%
74.81%
/ 5%
✗ NOT HALAL
DJIM 6.0%
/ 33%
19.0%
/ 33%
1.2%
/ 33%
74.81%
/ 5%
✗ NOT HALAL
MSCI 12.3%
/ 33%
39.1%
/ 33%
2.4%
/ 33%
74.81%
/ 5%
✗ NOT HALAL
S&P 6.0%
/ 33%
19.0%
/ 33%
1.2%
/ 33%
74.81%
/ 5%
✗ NOT HALAL
FTSE 12.3%
/ 33%
39.1%
/ 33%
2.4%
/ 50%
74.81%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-5.86
P/B Ratio
1.0
Revenue
$135,000
Growth: 526.9%
Current Ratio
3.6

Profitability

Gross Margin 95.7%
Operating Margin -718.1%
Net Margin 0.0%
Return on Equity (ROE) -295.2%
Return on Assets (ROA) -80.9%

Cash Flow & Balance Sheet

Operating Cash Flow-$16M
Free Cash Flow-$16M
Total Debt$574,000
Debt-to-Equity5.0
Current Ratio3.6
Total Assets$5M

Price & Trading

Last Close$2.79
50-Day MA$2.48
200-Day MA$5.08
Avg Volume102K
52-Week Range
$2.07
$17.25

About SeaStar Medical Holding Corp (ICU)

CEO
Mr. Eric Schlorff
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$10M
Currency
USD

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is SeaStar Medical Holding Corp (ICU) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), SeaStar Medical Holding Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is SeaStar Medical Holding Corp's debt ratio?

SeaStar Medical Holding Corp's debt ratio is 6.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 12.3%.

What are SeaStar Medical Holding Corp's key financial metrics?

SeaStar Medical Holding Corp has a market capitalization of $10M, and revenue of $135,000. Return on equity stands at -295.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.